Exact Mass: 363.0743

Exact Mass Matches: 363.0743

Found 31 metabolites which its exact mass value is equals to given mass value 363.0743, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Flufenacet

N-(4-Fluorophenyl)-N-(1-methylethyl)-2-((5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy)acetamide

C14H13F4N3O2S (363.0665)


CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9423; ORIGINAL_PRECURSOR_SCAN_NO 9420 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9408; ORIGINAL_PRECURSOR_SCAN_NO 9406 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9375; ORIGINAL_PRECURSOR_SCAN_NO 9373 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9386; ORIGINAL_PRECURSOR_SCAN_NO 9384 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9401; ORIGINAL_PRECURSOR_SCAN_NO 9399 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9344; ORIGINAL_PRECURSOR_SCAN_NO 9342 CONFIDENCE standard compound; INTERNAL_ID 8396 CONFIDENCE standard compound; INTERNAL_ID 3800

   
   
   
   
   

13-carboxaldehyde-8-oxocoptisine

13-carboxaldehyde-8-oxocoptisine

C20H13NO6 (363.0743)


   

Griseolic acid B

Griseolic acid B

C14H13N5O7 (363.0815)


   

Flufenacet

Pesticide5_Flufenacet_C14H13F4N3O2S_4-Fluoro-N-isopropyl-2-(5-trifluoromethyl-1,3,4-thiadiazol-2-yloxy)acetanilide

C14H13F4N3O2S (363.0665)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 709

   
   

Broperamole

Broperamole

C15H18BrN5O (363.0695)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate

tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate

C18H22BrNO2 (363.0834)


   

2-amino-6-(3-chlorophenyl)-5-methyl-3-nitro-4-phenylbenzonitrile

2-amino-6-(3-chlorophenyl)-5-methyl-3-nitro-4-phenylbenzonitrile

C20H14ClN3O2 (363.0774)


   

L 701324

7-chloro-4-hydroxy-3-(3-phenoxyphenyl)quinolin-2(1H)-one

C21H14ClNO3 (363.0662)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants L-701324 is a potent, orally active NMDA receptor antagonist that antagonizes the activity of the NMDA receptor by blocking its glycine B binding site. L-701324 binds with high affinity to rat brain membranes (IC50=2 nM). L-701324 has antidepressant activity[1][2][3].

   

9,9-SPIROBIFLUORENE

9,9-SPIROBIFLUORENE

C18H18ClNO3S (363.0696)


   

Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate

Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate

C20H14ClN3O2 (363.0774)


   
   
   

2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid

2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid

C17H17NO6S (363.0777)


   

4-Chloro-1-naphthyl 5-methoxy-2-(2-pyridinyl)-4-pyrimidinyl ether

4-Chloro-1-naphthyl 5-methoxy-2-(2-pyridinyl)-4-pyrimidinyl ether

C20H14ClN3O2 (363.0774)


   

S-(acet-2-yl)-glutathione

S-(acet-2-yl)-glutathione

C12H17N3O8S-2 (363.0736)


   

N-(4,6-dimethylpyrimidin-2-yl)-N-(2-methoxycarbonylphenyl)sulfonylcarbamimidate

N-(4,6-dimethylpyrimidin-2-yl)-N-(2-methoxycarbonylphenyl)sulfonylcarbamimidate

C15H15N4O5S- (363.0763)


   

4-chloro-N-(2-methoxy-1-phenazinyl)benzamide

4-chloro-N-(2-methoxy-1-phenazinyl)benzamide

C20H14ClN3O2 (363.0774)


   

4-[(2-Hydroxyanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

4-[(2-Hydroxyanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

C19H13N3O3S (363.0678)


   

6-[[[1-(4-chlorophenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine

6-[[[1-(4-chlorophenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine

C13H14ClN9S (363.0781)


   

3-[[4-(1,3,4-Oxadiazol-2-yl)phenyl]methyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide

3-[[4-(1,3,4-Oxadiazol-2-yl)phenyl]methyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide

C19H13N3O3S (363.0678)


   

2,4-Dimethyl-6-[(2,4,5-trifluorophenyl)methyl]-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

2,4-Dimethyl-6-[(2,4,5-trifluorophenyl)methyl]-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

C17H12F3N3OS (363.0653)


   

2-N-[(1S)-1-(3,5-dichlorophenyl)ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine

2-N-[(1S)-1-(3,5-dichlorophenyl)ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine

C15H15Cl2N7 (363.0766)


   

Tedatioxetine (hydrobromide)

Tedatioxetine (hydrobromide)

C18H22BrNS (363.0656)


Tedatioxetine (Lu AA24530) hydrobromide acts as a serotonin and norepinephrine (NE)-preferring triple reuptake inhibitor (TRI) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist[1]. ,

   

(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)


   

(2r,5s,6r,6ar)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2r,5s,6r,6ar)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)


   

5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)